2009
DOI: 10.1016/j.jaci.2008.12.598
|View full text |Cite
|
Sign up to set email alerts
|

High Frequency of CF Transmembrane Conductance Regulator (CFTR) Mutations in a Population with Persistent Asthma and/or Chronic Rhinosinusitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…A small retrospective US study of patients with CRS who underwent full sequencing of CFTR (n=68) found 38% of these patients had mutations in CFTR (n=26). 68 The prevalence of CFTR mutations was slightly higher in CRS patients with comorbid asthma (42%, or 16 out of 38 patients), and even higher in their very small sample of patients with CRSwNP (66%, or 4 out of 6 CRSwNP patients in the study). 68 The authors estimated they would have missed 75% of CFTR mutation carriers (i.e., 30 of 41 patients) if they had employed only genetic screening for the 23 most common CFTR mutations for CF patients of European ancestry.…”
Section: Genetics Of Crs: Current State Of the Field And Limitations mentioning
confidence: 67%
See 2 more Smart Citations
“…A small retrospective US study of patients with CRS who underwent full sequencing of CFTR (n=68) found 38% of these patients had mutations in CFTR (n=26). 68 The prevalence of CFTR mutations was slightly higher in CRS patients with comorbid asthma (42%, or 16 out of 38 patients), and even higher in their very small sample of patients with CRSwNP (66%, or 4 out of 6 CRSwNP patients in the study). 68 The authors estimated they would have missed 75% of CFTR mutation carriers (i.e., 30 of 41 patients) if they had employed only genetic screening for the 23 most common CFTR mutations for CF patients of European ancestry.…”
Section: Genetics Of Crs: Current State Of the Field And Limitations mentioning
confidence: 67%
“…68 The prevalence of CFTR mutations was slightly higher in CRS patients with comorbid asthma (42%, or 16 out of 38 patients), and even higher in their very small sample of patients with CRSwNP (66%, or 4 out of 6 CRSwNP patients in the study). 68 The authors estimated they would have missed 75% of CFTR mutation carriers (i.e., 30 of 41 patients) if they had employed only genetic screening for the 23 most common CFTR mutations for CF patients of European ancestry. 68 As gene sequencing becomes a feasible and inexpensive method for investigation, applying this technology to further study of CFTR in CRS may prove worthwhile.…”
Section: Genetics Of Crs: Current State Of the Field And Limitations mentioning
confidence: 67%
See 1 more Smart Citation
“…In the context of these dramatic changes in mucus quantity and quality, the expansion and programming of tuft cells that enables production of PGE2 may serve to hydrate the mucus and promote clearance via CFTR. The specific importance of CFTR activity in maintaining fluid transport in the allergic airway is reinforced by the observation that CFTR gene mutations are found in patients with asthma or nasal polyps (without cystic fibrosis) at higher rates than healthy control populations (34). While PGE2-enhanced mucus transport may be beneficial in the context of pathological mucus production in the allergic airway, further studies are needed to define the full spectrum of PGE2 effects, as well as the function of other secreted factors derived from tuft cells.…”
Section: Discussionmentioning
confidence: 99%
“…There is currently no published GWAS performed only on patients with CRSwNP but there is a pooling-based GWAS done on patients with CRS (both CRSsNP and CRSwNP) [ 13 ] as well as several studies of candidate genes [ 14 ]. These studies have implicated several genes and pathways such as the cystic fibrosis transmembrane conductance regulator gene ( CFTR ) [ 15 , 16 ] and, among others, genes involved in immunity [ 17 20 ], inflammation [ 21 , 22 ], tissue remodelling [ 20 ] and arachidonic acid metabolism [ 23 ]…”
Section: Introductionmentioning
confidence: 99%